The CYP2C9 genotype predicts the blood pressure response to irbesartan: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA) trial.

Source:http://linkedlifedata.com/resource/pubmed/id/12359989

Download in:

View as

General Info

PMID
12359989